Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Biote (BTMD) EPS (Weighted Average and Diluted) (2021 - 2025)

Biote (BTMD) has 5 years of EPS (Weighted Average and Diluted) data on record, last reported at $0.09 in Q2 2025.

  • For Q2 2025, EPS (Weighted Average and Diluted) rose 142.86% year-over-year to $0.09; the TTM value through Jun 2025 reached $0.13, down 69.05%, while the annual FY2024 figure was $0.09, 30.77% down from the prior year.
  • EPS (Weighted Average and Diluted) reached $0.09 in Q2 2025 per BTMD's latest filing, down from $0.37 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $1.87 in Q4 2021 and bottomed at -$2.35 in Q3 2022.
  • Average EPS (Weighted Average and Diluted) over 5 years is -$0.03, with a median of -$0.01 recorded in 2024.
  • Peak YoY movement for EPS (Weighted Average and Diluted): tumbled 88.22% in 2022, then soared 408.33% in 2025.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $1.87 in 2021, then crashed by 88.22% to $0.22 in 2022, then surged by 45.45% to $0.32 in 2023, then crashed by 165.62% to -$0.21 in 2024, then skyrocketed by 142.86% to $0.09 in 2025.
  • Per Business Quant database, its latest 3 readings for EPS (Weighted Average and Diluted) were $0.09 in Q2 2025, $0.37 in Q1 2025, and -$0.21 in Q2 2024.